Table-II.
Diagnostic Immunophenotyping done by multi parameter flow cytometry (n=26).
| Immunophenotyping | Positive | Negative | Partial positive* |
|---|---|---|---|
| CYTO-CD3 | 23(88.5%) | 3(11.5%) | 00 |
| TdT | 11(42.5%) | 12(46.15%) | 3(11.5%) |
| CD99 | 20(76.9%) | 5(19.23%) | 1(3.8) |
| CD1a | 5(19.2%) | 20(76.92%) | 1(3.8%) |
| CD34 | 5(19.2%) | 18(69.23%) | 3(11.5%) |
| HLA-DR | 4(15.4%) | 20(76.92%) | 2(7.7%) |
| S-CD3 | 2(7.7%) | 23(88.5%) | 1(3.8%) |
| CD4 | 12(46.2%) | 14(53.84%) | 00 |
| CD8 | 6(23.1%) | 17(65.38%) | 3(11.5%) |
| CD7 | 23(88.5%) | 3(11.5%) | 00 |
| CD2 | 20(76.9%) | 4(15.4%) | 2(7.7%) |
| CD5 | 21(80.8%) | 3(11.5%) | 2(7.7%) |
*
For a marker to be considered partially positive, 20% of the population in question should express that marker.